Pharma's Almanac TV
PA TV
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2021 Cell & Gene Therapy Report
2021 Monoclonal Antibody & Recombinant Protein Market Report
2022 Sterile Drug Market Report
2022 API Market Report
2020 OSD Market Report
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
More+
Staffing
Media Kit
Investment
194 Articles Available
1
9
Can't find what you're looking for? Try our
advanced search
.
Vaccines
IDT Biologika is Increasing its Production Capacity of Vaccines – Saxony-Anhalt's Prime Minister Reiner Haseloff Visited the New Facilities
PR-M01-22-13
Cell and Gene Therapy
Supporting Innovative Biotechs to Bring Cell and Gene Therapies to Market
PAO-11-21-CL-15
Biologics
An Evolving Biologics Landscape and Driving Innovation and Opportunity
PAO-11-21-CL-16
Investing in mRNA Production
Sale
Arranta Bio Announces Completion of Sale of Florida Site and Progress on $150M Investment Plan to Expand Development and Commercial Manufacturing Services
Cell and Gene Therapy
A Novel Approach to Drive Disruptive Innovation in Cell and Gene Therapy
PAO-10-21-CL-14
High Potency
Streamlining Highly Potent Drug Commercialization
PAO-04-21-CL-04
COVID-19 Impacts
Q: Putting aside COVID-19 vaccines and therapeutics, what do you think will be the most significant development in the industry in 2021?
PAO-03-21-NI-01
The Future of Healthcare
How Does Dynamk Capital Envision the Future of the Pharma/Biopharma Industry?
PAP-Q4-20-RT2-013
Investment
SEQENS Invests in New Technologies
PR-M11-20-015
Investment
Intuitive Launches $100 Million Venture Capital Fund
PR-M10-20-17
Strategy
Vetter Continues its Long-term Investment Strategy to Sustain Future Growth
PR-M10-20-13
Northern Ireland
COVID-19 and the Growing Need for Dual-Source Supply Chains
PAP-Q3-20-CL-022
Medical Devices
Investing with a Focus on Medical Devices and Digital Health
PAP-Q3-20-CL-023
Investment
Altis Biosystems Announces Completion of a $3.1 Million Seed Investment Led by VentureSouth
PR-M08-20-NI-18
Financing
PMV Pharma Closes $70 Million in Series D Financing
PR-M08-20-NI-07
COVID-19 Vaccine Funding
Sanofi and GSK Selected for Operation Warp Speed to Supply United States Government with 100 Million Doses of COVID-19 Vaccine
PR-M08-20-NI-05
Investment
AlloVir Announces Pricing of Upsized Initial Public Offering
PR-M08-20-NI-04
Investment
DFC to Sign Letter of Interest for Investment in Kodak’s Expansion Into Pharmaceuticals
PR-M08-20-NI-01
Antibiotics
Sandoz Announces Plans for Joint Investment to Help Strengthen Future of Antibiotics Manufacturing in Europe
PR-M07-20-NI-38
Funding
Blackstone Announces $4.6 Billion Final Close of Life Sciences Fund
PR-M07-20-NI-012
Osivax Receives Over EUR 30M in Public Funding to Support Development of Universal Coronavirus and Influenza Vaccines
PR-M07-20-NI-010
COVID-19 Vaccine Manufacturing
Emergent BioSolutions Signs Five-Year Agreement for Large-Scale Drug Substance Manufacturing for Johnson & Johnson’s Lead COVID-19 Vaccine Candidate
PR-M07-20-NI-007
Funding
Novavax Announces $1.6 Billion Funding from Operation Warp Speed
PR-M07-20-NI-006
1
9
»
